Terkko Navigator / Radiotherapy & Oncology

Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups

Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study

The blurred line between the art and science of medicine

Ensuring safety and sustainability of radiotherapy services during the COVID-19 pandemic in resources constrain country: An Indonesian experience

Changes in radiotherapy practice during COVID-19 outbreak in Turkey: A report from the Turkish Society for Radiation Oncology

Volume-dependent dose–response of the intestinal stem cell niche and lymphoid tissue

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

Postoperative radiotherapy for WHO grade II–III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01)

Under the coronavirus disease 2019 (COVID-19) pandemic circumstance, how to administrate cancer patients with fever during radiotherapy

Post-lockdown management of oncological priorities and postponed radiation therapy following the COVID-19 pandemic: Experience of the Institut Curie

Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer – Decision criteria in routine practise

Feasibility of cone beam CT-guided library of plans strategy in pre-operative gastric cancer radiotherapy

Reduced increase of calcium scores using breath-hold in left-sided whole breast irradiation

Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial

Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration

Dose prediction using a deep neural network for accelerated planning of rectal cancer radiotherapy

Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching

Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?

Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy

Bracing for impact with new 4R’s in the COVID-19 pandemic – A provincial thoracic radiation oncology consensus

Cancer patients in Covid-19 era: Swimming against the tide

Covid-19 outbreak in a major radiation oncology department; which lessons should be taken?

The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review

COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic – A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Inte

Can we prevent COVID-19 from causing victims among uninfected cancer patients?

Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy

Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer

Feasibility of 3D tracking and adaptation of VMAT based on VMAT-CT

Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT)

AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC

Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China

Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer

Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer

Long-term defects of nasal epithelium barrier functions in patients with nasopharyngeal carcinoma post chemo-radiotherapy

Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics

Corrigendum to “Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis” [Radiother Oncol 141 (2019) 56–61]

Development of transient radioresistance during fractionated irradiation in vitro

An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective

Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose

Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening

Role of T0 status in overall survival for unresectable stage III non-small cell lung cancer: A NCDB analysis

FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status

Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer

SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach

The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care

Implementing an online radiotherapy quality assurance programme with supporting continuous medical education – report from the EMBRACE-II evaluation of cervix cancer IMRT contouring

Results of the ACCEL trial: Dosimetry in accelerated partial breast irradiation

3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy